Switch theme
Sign up to access all valuation multiples
Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
2000
466
LTM Revenue $118M
LTM EBITDA $14.5M
$816M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nanosonics has a last 12-month revenue of $118M and a last 12-month EBITDA of $14.5M.
In the most recent fiscal year, Nanosonics achieved revenue of $108M and an EBITDA of $13.7M.
Nanosonics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nanosonics valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $105M | $108M | XXX | XXX | XXX |
| Gross Profit | $57.4M | $83.1M | XXX | XXX | XXX |
| Gross Margin | 55% | 77% | XXX | XXX | XXX |
| EBITDA | $18.5M | $13.7M | XXX | XXX | XXX |
| EBITDA Margin | 18% | 13% | XXX | XXX | XXX |
| Net Profit | $2.4M | $12.5M | XXX | XXX | XXX |
| Net Margin | 2% | 12% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nanosonics's stock price is AUD 5 (or $3).
Nanosonics has current market cap of AUD 1.4B (or $901M), and EV of AUD 1.3B (or $816M).
See Nanosonics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $816M | $901M | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nanosonics has market cap of $901M and EV of $816M.
Nanosonics's trades at 6.9x LTM EV/Revenue multiple, and 56.1x LTM EBITDA.
Analysts estimate Nanosonics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nanosonics and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $816M | XXX | XXX | XXX |
| EV/Revenue | 7.1x | XXX | XXX | XXX |
| EV/EBITDA | 55.7x | XXX | XXX | XXX |
| P/E | 96.0x | XXX | XXX | XXX |
| P/E/Growth | 2.8x | XXX | XXX | XXX |
| EV/FCF | 67.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNanosonics's NTM/LTM revenue growth is 12%
Nanosonics's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Nanosonics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nanosonics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nanosonics and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -26% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 38% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 19% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 78% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nanosonics acquired XXX companies to date.
Last acquisition by Nanosonics was XXXXXXXX, XXXXX XXXXX XXXXXX . Nanosonics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Nanosonics founded? | Nanosonics was founded in 2000. |
| Where is Nanosonics headquartered? | Nanosonics is headquartered in Australia. |
| How many employees does Nanosonics have? | As of today, Nanosonics has 466 employees. |
| Who is the CEO of Nanosonics? | Nanosonics's CEO is Mr. Michael Kavanagh. |
| Is Nanosonics publicy listed? | Yes, Nanosonics is a public company listed on ASX. |
| What is the stock symbol of Nanosonics? | Nanosonics trades under NAN ticker. |
| When did Nanosonics go public? | Nanosonics went public in 2007. |
| Who are competitors of Nanosonics? | Similar companies to Nanosonics include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nanosonics? | Nanosonics's current market cap is $901M |
| What is the current revenue of Nanosonics? | Nanosonics's last 12-month revenue is $118M. |
| What is the current EBITDA of Nanosonics? | Nanosonics's last 12-month EBITDA is $14.5M. |
| What is the current EV/Revenue multiple of Nanosonics? | Current revenue multiple of Nanosonics is 6.9x. |
| What is the current EV/EBITDA multiple of Nanosonics? | Current EBITDA multiple of Nanosonics is 56.1x. |
| What is the current revenue growth of Nanosonics? | Nanosonics revenue growth between 2023 and 2024 was 2%. |
| Is Nanosonics profitable? | Yes, Nanosonics is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
